Viatris Inc. (VTRS) financial statements and ratios from SEC XBRL: revenue $14.6B (TTM), net margin -24.6%, revenue growth 8.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $14.30B |
| Revenue (TTM) | $14.6B |
| Net Margin | -24.6% |
| Operating Margin (TTM) | 1.0% |
| Net Debt / EBITDA | 4.3 |
| Revenue Growth (YoY) | 8.1% |
| EPS Growth (YoY) | -105.9% |
| FCF Growth (YoY) | -29.3% |
| EV / EBITDA | 10.8 |
| Price / Book | 1.31 |
| Price / Sales | 1.32 |
| FCF Yield | 9.3% |
| Altman Z-Score | 0.72 (distress) |
| Piotroski F-Score | 4/9 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.7 |
VTRS overview · VTRS earnings · VTRS KPIs · VTRS documents · VTRS ownership · VTRS peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.